logo
#

Latest news with #Energy+Focus

VIVAZEN ® and MoreBetter ® Announce Landmark Real-World Evidence Study on Its Proprietary Extract, Highlighting the Power of Botanicals in Daily Wellness
VIVAZEN ® and MoreBetter ® Announce Landmark Real-World Evidence Study on Its Proprietary Extract, Highlighting the Power of Botanicals in Daily Wellness

Business Wire

time6 days ago

  • Health
  • Business Wire

VIVAZEN ® and MoreBetter ® Announce Landmark Real-World Evidence Study on Its Proprietary Extract, Highlighting the Power of Botanicals in Daily Wellness

PHOENIX--(BUSINESS WIRE)--VIVAZEN ®, a trusted leader in botanical-based wellness products, proudly shares the results of a first-of-its-kind Real-World Evidence (RWE) study using its proprietary extract. The study was conducted in partnership with MoreBetter ®, a leading real-world data and research platform. The study tracked the daily experiences of real users over 21 days and revealed statistically significant improvements in energy, focus, and productivity without the use of caffeine or stimulants.* Amid growing concern over adulterated products, this study offers timely, real-world data to distinguish authentic botanical formulas from dangerous synthetics and reinforces the need for science-based evaluation of kratom in everyday use. Share Scientifically Measured, Naturally Effective The RWE study provided consistent daily feedback on the Energy + Focus supplement, a proprietary formula, which resulted in measurable and meaningful outcomes: 25% increase in daily energy* 66% reported improved productivity* 63% experienced reduced fatigue* 61% noted better focus* 'This study exemplifies how real-world evidence can transform anecdotal usage into actionable science,' said Steve Curtis, CEO of VIVAZEN. 'Botanicals have played a critical role in traditional health practices for centuries, but research like this is essential to bring credibility and scientific rigor to the future of functional wellness.' Why This Research Matters Now In July 2025, the FDA announced plans to schedule 7-hydroxymitragynine (7-OH), a potent synthetic derivative of kratom, as a Schedule I controlled substance, citing its opioid-like risks and safety data. Crucially, regulators emphasized that natural kratom leaf products are not the target of this action. Amid growing concern over adulterated products, this study offers timely, real-world data to distinguish authentic botanical formulas from dangerous synthetics and reinforces the need for science-based evaluation of kratom in everyday use. Advancing Wellness Through Research & Transparency To help advance public understanding and transparency, VIVAZEN partnered with the Network of Applied Pharmacognosy (NAP), a nonprofit dedicated to accelerating research and education around natural medicines by centering lived experience and community engagement. In alignment with this mission, NAP has published a summary of the study findings on its public platform, making the results more accessible to researchers, educators, and everyday consumers alike. Read the full blog post here Help Shape the Future of Botanical Science This RWE study highlights a broader movement to validate natural products through real-world data, offering consumers and health care providers a clearer understanding of product efficacy outside of a lab environment. As consumers increasingly seek non-synthetic, plant-based alternatives, real-world studies provide critical insights that help build trust, transparency, and scientific credibility. *VIVAZEN ® products are not intended to diagnose, treat, cure or prevent any disease and these statements have not been evaluated by the FDA.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store